Attached files
file | filename |
---|---|
10-K - 10-K - Flexion Therapeutics Inc | d686907d10k.htm |
EX-10.5 - EX-10.5 - Flexion Therapeutics Inc | d686907dex105.htm |
EX-31.2 - EX-31.2 - Flexion Therapeutics Inc | d686907dex312.htm |
EX-32.1 - EX-32.1 - Flexion Therapeutics Inc | d686907dex321.htm |
EX-32.2 - EX-32.2 - Flexion Therapeutics Inc | d686907dex322.htm |
EX-10.9 - EX-10.9 - Flexion Therapeutics Inc | d686907dex109.htm |
EX-10.11 - EX-10.11 - Flexion Therapeutics Inc | d686907dex1011.htm |
EX-10.7 - EX-10.7 - Flexion Therapeutics Inc | d686907dex107.htm |
EX-31.1 - EX-31.1 - Flexion Therapeutics Inc | d686907dex311.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-193907) of Flexion Therapeutics, Inc. of our report dated March 28, 2014 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 28, 2014